Shasqi VP of Research, Travis Biechele, PhD, and Founder and CEO, José Mejía Oneto, MD, PhD, will both be sharing data from Shasqi's CAPAC platform
Travis Biechele will present "Understanding the drivers of target independent toxicities associated with ADCs and solutions to overcome them" on November 4th at 10:30am PST.
José Mejía Oneto will present "Click Chemistry Enabled Pre-targeting as a Solution to Target-independent ADC Toxicities" on November 6th at 12pm PST
The team will also be presenting two posters.
